Dianthus Therapeutics, Inc. /DE/ Annual Net Income (Loss) Attributable to Parent in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2023.
  • Dianthus Therapeutics, Inc. /DE/ Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$25.2M, a 70.5% decline year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$67.1M, a 55.6% decline year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ annual Net Income (Loss) Attributable to Parent for 2023 was -$43.6M, a 53% decline from 2022.
  • Dianthus Therapeutics, Inc. /DE/ annual Net Income (Loss) Attributable to Parent for 2022 was -$28.5M, a 117% decline from 2021.
  • Dianthus Therapeutics, Inc. /DE/ annual Net Income (Loss) Attributable to Parent for 2021 was -$13.1M, a 82.5% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$43.6M -$15.1M -53% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$28.5M -$15.4M -117% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$13.1M +$61.8M +82.5% Jan 1, 2021 Dec 31, 2021 8-K 2023-12-21
2020 -$74.9M +$1.83M +2.39% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-08
2019 -$76.8M -$19.3M -33.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-03
2018 -$57.5M -$22M -62.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-03
2017 -$35.5M -$26.1M -276% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-03
2016 -$9.43M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.